Prof Development   |   Print Page   |   Contact Us   |   Sign In   |   Join SRNT
Treatment Research Network Leadership
Share |

Advisory Committee

Treatment Research Network Co-Chairs:

Megan Piper, Ph.D.

Dr. Megan Piper is an Associate Professor at the University of Wisconsin, Madison and the Associate Research Director of the UW Center for Tobacco Research and Intervention. Her research focuses on understanding and treating tobacco dependence, with an additional interest in different populations of smokers who have more difficulty quitting, such as women and smokers with mental illness.  In 2014, Dr. Piper received the Russell-Jarvik Young Investigator Award for her contributions to the field from the Society for Research on Nicotine and Tobacco. Dr. Piper serves as an Associate Editor for the journal Nicotine & Tobacco Research.

Leonie Brose, Ph.D.

Dr Leonie Brose is a Lecturer in Addictions at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. She completed her PhD at Royal Holloway, University of London, followed by a post-doctoral position at University College London and the National Centre for Smoking Cessation and Training.

Her research has covered clinical effectiveness of stop smoking intervention, practitioner training and electronic cigarettes. In December 2015, she has started a Cancer Research UK/BUPA Foundation Fellowship in Cancer Prevention to focus on smoking cessation in smokers with mental health problems.




Advisory Committee Members:

Janice Blalock, Ph.D.

Janice Blalock, Ph.D., is an Associate Professor in the Department of Behavioral Science and Assistant Director of the Tobacco Treatment Program at University of Texas MD Anderson Cancer Center. She is a clinical psychologist with 18 years of experience conducting clinical research in the area of smoking cessation and treatment of depressive and anxiety disorders. Her research is focused on understanding the role that comorbid psychiatric disorders and related emotional processes play in the development and maintenance of nicotine dependence; and development of treatments for this population of smokers. She has conducted NIDA and NIMH-funded studies evaluating the efficacy of combined depression and smoking cessation interventions in pregnant smokers with high levels of depressive symptoms and in smokers with chronic forms of current depressive disorders. She also has interest in evaluating smoking cessation treatments that are specifically tailored to meet the needs of cancer patients who have difficulty quitting following diagnosis. She conducted an NCI-funded study evaluating a novel smoking cessation counseling approach for cancer patients. She has published numerous articles on treatment outcomes of these clinical trials and studies evaluating the impact of clinical depression on withdrawal and abstinence outcomes. She holds a Ph.D. in clinical psychology from Virginia Polytechnic Institute and State University.


Lisa Fucito, Ph.D.

Lisa Fucito, PhD is an Assistant Professor of Psychiatry at the Yale School of Medicine and Director of the Tobacco Treatment Service at Smilow Cancer Hospital at Yale-New Haven Hospital. Her program of research is focused on developing novel interventions for smoking and heavy drinking and understanding moderators and mechanisms of treatment response. She currently has a career award from the National Institute of Alcohol Abuse and Alcoholism to develop and evaluate an integrated behavioral intervention for heavy-drinking smokers. Dr. Fucito is interested in treatments that promote multiple behavior change and are practical in primary healthcare settings. In addition to these research activities, Dr. Fucito serves as Co-Chair of the Treatment Research Network Committee of the Society for Research on Nicotine and Tobacco and is  an Associate Editor for the journal Nicotine & Tobacco Research.



Anne M. Joseph, M.D., MPH

Dr. Joseph is a Wexler Professor of Medicine and general internist in the Department of Medicine. She received her medical training at the University of Michigan and received a Masters of Public Health in Epidemiology from the University of Minnesota. She is currently directing the Applied Clinical Research Program in the Department of Medicine. Her primary research interests are in tobacco control. Her work has focused on smoking cessation and smoking reduction interventions for special populations of smokers that experience unique barriers to delivery of tobacco treatment. Dr. Joseph is past president of the Society for Research on Nicotine and Tobacco, Co-Chair of the Medical School Promotion and Tenure Committee and a member of the University of Minnesota Women’s Faculty Cabinet.




Marc L. Steinberg, Ph.D.

Dr. Marc Steinberg is an Associate Professor of Psychiatry and Associate Director, Division of Addiction Psychiatry at Rutgers Robert Wood Johnson Medical School. Dr. Steinberg’s research focuses on tobacco use and dependence, including tobacco dependence treatment development, tobacco use in smokers with psychiatric comorbidity, the relationship between smoking and task persistence/distress tolerance, and motivational interviewing as an approach to encourage smokers to make a quit attempt.


In addition to serving on the SRNT Treatment Research Network’s Advisory Committee, Dr. Steinberg serves on the Treatment Research Network’s Communications Committee and the SRNT Electronic Communications Committee. He is a Deputy Editor for the journal Nicotine & Tobacco Research.



Joanna Streck

Joanna Streck is a graduate student in the clinical psychology program at the University of Vermont. Her research takes place at the Vermont Center on Behavior & Health where she works on a trial examining the effects of reduced nicotine content cigarettes on different populations particularly vulnerable to smoking.  Joanna is interested in the cross section between psychopathology, illicit substance use and smoking outcomes as well as the prospect of different novel harm reduction strategies such as reduced nicotine content cigarettes.  Joanna serves as the Network Operations Coordinator for the Treatment Research Network.




Benjamin Toll, Ph.D.

Dr. Benjamin Toll is licensed clinical psychologist, an Associate Professor of Public Health Sciences, Chief of Tobacco Cessation and Health Behaviors, and Co-Director of the Lung Cancer Screening program at the Hollings Cancer Center and the Medical University of South Carolina. He specializes in treatment of tobacco use disorders, alcohol use disorders, and improvement of health behaviors.

Dr. Toll has received grants from the National Institutes of Health, including the National Cancer Institute, and he is an author of over 65 peer-reviewed publications relating to nicotine and tobacco research, including a policy statement from the American Association for Cancer Research (AACR) encouraging physicians to provide tobacco treatment for cancer patients and the American College of Chest Physician (ACCP) treatment guidelines for smoking cessation amongst lung cancer patients. He is also holds leadership positions in national associations relating to tobacco treatment research. Dr. Toll is the Co-Chair of the Treatment Network of the Society for Research on Nicotine and Tobacco (SRNT), and a Member of the AACR Tobacco and Cancer Subcommittee.


Dr. Toll’s research has focused on testing novel smoking cessation treatments, and he has conducted numerous clinical trials in this regard. Many of his studies have investigated promotion of smoking cessation through novel message framing and motivational interventions, including those delivered via telephone and in person. Dr. Toll has tested several pharmacological and counseling interventions, and he also has expertise in the measurement of tobacco use and tobacco related syndromes (e.g., withdrawal, craving) and mediators and moderators of response to treatment. He has served as a reviewer for numerous peer-reviewed publications, including the Surgeon General’s Report (The Health Consequences of Smoking: 50 Years of Progress, Chapter: Cigarette Smoking and Adverse Health Outcomes in Cancer Patients and Survivors).


Return to SRNT homepage

Return to Treatment Research Network homepage

(last updated 7/31/2017)

Connect With Us
Membership Management Software Powered by YourMembership  ::  Legal